首页>美国卫生研究院文献>Liver Cancer

Liver Cancer

【机译】：肝癌

ISSN：-
出版周期：Quarterly
语言：English

起始发布年份：2012
出版者：Basel : S. Karger
出版地：Switzerland

数据库引入：PubMed: v1, 2012-, PMC

MeSH词表主题词：Liver Neoplasms*

备注：Also issued online.展开▼

期刊论文

热门论文

年度选择

更多>>

全选（0）

1.Treatment of Hepatocellular Carcinoma in the Community: Disparities in Standard Therapy

机译：社区肝细胞癌的治疗：标准疗法的差异
- 作者：Linda C. Harlan;Helen M. Parsons;Charles L. Wiggins;Jennifer L. Stevens;Yehuda Z. Patt
- 期刊名称：《Liver Cancer》 | 2015年第1期
2.The 8th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2017). The Art Science of Conquering Liver Cancer. Singapore July 14–16 2017: Abstracts

机译：第八届亚太原发性肝癌专家会议（APPLE 2017）。战胜肝癌的艺术与科学。新加坡2017年7月14日至16日：摘要
- 作者：Sheng-Long Ye;Masatoshi Kudo;Vincent Wong;Kwang-Hyub Han;Seng Gee Lim;Valerie Chew;Lu Pan;Liyun Lai;Camillus Chua;Chun Jye Lim;Kiat Hon Lim;Han Chong Toh;Brian K.P. Goh;Alexander Chung;Pierce K.H. Chow;Salvatore Albani;Weiwei Zhai;Michiie Sakamoto;Gi Hong Choi;Ho-Seong Han;Norihiro Kokudo;Nobuhisa Akamatsu;Kyung-Suk Suh;Gerold Meinhardt;Jordi Bruix;Jeong Min Lee;Cher Heng Tan;Pek-Lan Khong;Peter R. Galle;Ji-Hong Hong;Tomoki Kimura;Yun Hwan Kim;Ryosuke Tateishi;Stephen L. Chan;Thomas Yau;Victor Lee;Victor Wong;Stanley Lam;Patty Ho;Matthew Szeto;Sau Ha Ng;Josephine Ko;Maria Lung;To-Wai Leung;Wahyuni Atmodjo;George Mathew;Abidin Pandianta;Riska Nufika;Young Larasati;Imelda Winoto;Indra Wijaya;Darti Wibisono;Xin-Rong Yang;Joe;Poh Sheng Yeong;Yang Cheng;Karen Teng;Yannick Simoni;Seng Gee Lim;Pierce Chow;Tony Lim;Han Chong Toh;Su Pin Choo;Evan Newell;Hak Soo Kim;Yong Kyun Cho;Sang Hyuk Lee;Min Soo Kim;Jin Wook;Kevin Ka-wan Chu;Albert Chi-yan Chan;Terrence Hui;Tong Kuan Chuah;Hsien Min Low;Cher Heng Tan;Kiyoshi Hasegawa;Hiroji Shinkawa;Satoshi Yamamoto;Kiyohiko Omichi;Junichi Arita;Nobuhisa Akamatsu;Junichi Kaneko;Yoshihiro Sakamoto;Norihiro Kokudo;Chao-Wei Lee;Darren Chua;Sung Whan Cha;Jae Uk Chong;Dai Hoon Han;Gi Hong Choi;Jinsil Seong;Kwang Hyub Han;Kyung Sik Kim;Jin Sub Choi;Y.H. Chen;Z.F. Wu;Y.Y. Dong;B.Y. Yuan;L. Zhang;Q. Lin;J.C. Cheng;Z.C. Zeng;Hyun-Cheol Kang;Jin Ho Kim;Kim Woo Chul;Mi-Sook Kim;Ki Mun Kang;Jin Hee Kim;Chen-Chun Lin;Yi-Chung Hsieh;Wei-Ting Chen;Kar-Wai Lui;Shi-Ming Lin;Charing Chong;Seheon Chang;Jihyun An;Ha Il Kim;Jina Park;Danbi Lee;Kang Mo Kim;Young-Suk Lim;Han Chu Lee;Young-Hwa Chung;Yung Sang Lee;Ju Hyun Shim;Rene Luis Filarca;David Ng;Sean Yan;Lo Richard;Apoorva Gogna;Su Pin Choo;Brian Goh;Mihir Gandhi;Kelvin Loke;Pierce Chow;Han Chiong Toh;Chiun Hsu;Tsai-Sheng Yang;Chia-Jui Yen;Chia-Chi Lin;Rebecca Cheng;Jia-Ning Wang;Jin Wang;Yee Chao;Yu-Yun Shao;Yi-Ping Hung;Jan-Mou Lee;Chiun Hsu;Chih-Hung Hsu;Sungsoo Kim;Inseung Choi;Jae-Jun Shim;Sung Eun Ahn;Seong Jin Park;Chi Hyuck Oh;Hyun Rim Choi;Byung-Ho Kim;Yoon Jun Kim;Joon Yeul Nam;An Na Seo;Ghilsuk Yoon;Vireak Chun;Sun-Jae Lee;Eun jeong Jang;Won Il Jang;Mi-Sook Kim;Wonwoo Kim;Jae Hoon Jeong;Jae-Sung Kim;Huang Daniel;Yock Young Dan;Nur Halisah Binte Jumat;Alfred Kow;Krishnakumar Madhavan;Iyer Shridhar;Glenn Bonney;Lei Zhou;Naoki Morimoto;Norio Isoda;Kouichi Miura;Shunij Watanabe;Yoshinari Takaoka;Hiroaki Nomoto;Mamiko Tsukui;Kozue Murayama;Takuya Hirosawa;Hironori Ymamoto;Eshani Mathew;Nivedita Nadkarni;Su Pin Choo;Han Chong Toh;David Tai;Brian Goh;Pierce Chow;Timothy Shuen;Han Chong Toh;Yogen Saunthararajah;Francis Enane;Xu-Xiao Chen;Mehul Lamba;Hannah Giles;Catherine Stedman;Akhil Deepak Vatvani;Devita Widjaja;Kalis Waren;Moses Leonardo;Andree Kurniawan;Khasbazar Ariunaa;Kah-Hoe Pierce Chow;Gandhi Mihir;Sook-Kyung Lee;Jin Sook Kim;Ju Yeon Oh;Sung Hoon Kim;Eun Kyung Hong;Joong-Won Park;Chang Woo Shim;Joong-Won Park*;So Hee Kim;Jin Sook Kim;Bo Hyun Kim;Sung Hoon Kim;Eun Kyung Hong;Yu Bin Tan;Chit Lai Chee;Han Chong Toh;Timothy Wai Ho Shuen;Chloe Yuan Ai Yeo;Lip Seng Koh;Bo Hu;Jun Sik Yoon;Yu Rim Lee;Young-Oh Kweon;Won Young Tak;Se Young Jang;Soo Young Park;Keun Hur;Hee Yeon Kim;Chang Wook Kim;Jin Ah Kim;Mi Ju Cheon;Su Lim Lee;Yoo Dong Won;Eshani Mathew;Edwin Yang;Tiffany Hennedige;San Meng Lim;John Allen;Adrian Low;Choon Hua Thng;Pierce Chow;Chikara Ogawa;Masatoshi Kudo;Mitsushige Shibatoge;Yue Sun Cheung;Paul Bo San Lai;Philip Ching Tak Ip;Charing Ching Ning Chong;Julian Tsang;Chung Mau Lo;Kenneth Chok;Kuo-Shyang Jeng;Charing Chong;Ha II Kim;Jihyun An;Seheon Chang;Jina Park;Danbi Lee;Kang Mo Kim;Young-Suk Lim;Han Chu Lee;Young-Hwa Chung;Yung Sang Lee;Ju Hyun Shim;Ju Hyun Shim;Jihyun An;Seheon Chang;Ha Il Kim;Jina Park;Danbi Lee;Kang Mo Kim;Young-Suk Lim;Han Chu Lee;Young-Hwa Chung;Yung Sang Lee;Tae Hyung Kim;Soon Ho Um;Han Ah Lee;Jung Mi Chang;Dae Hoe Ku;Yeon Seok Seo;Chai Hong Rim;Jinsil Seong;Joong Yeol Woo;Sangjoon Park;Sang Min Yoon;Jinhong Jung;In-Hye Jung;Jong Hoon Kim;Mohamed Kohla;Yasmin Omar;Medhat Assem;Gasser El-Azab;Enas Maged;Mohamed Kohla;Asmaa Gomaa;Asmaa Abdelhaie;Gasser El-Azab;Mohamed Saied;Enas Maged;Akihiro Deguchi;Dana Pramudya;Titong Sugihartono;Husin Thamrin;Ummi Maimunah;Amie Vidyani;Poernomo Budi Setiawan;Poernomo Budi Setiawan;Dana Pramudya;Annisa Zahra Mufida;Annisa Zahra Mufida;Herry Purbayu;Ulfa Kholili;Budi Widodo;Iswan Abas Nusi;Poernomo Budi Setiawan;Alexander Yip;Poh Seng Tan;Kieron Lim;Wee Thong Neo;Kamarjit Singh Mangat;Alfred Kow;Krishnakumar Madhavan;Maureen Da Costa;David Chen;Sean Dulloo;Azusa Sakamoto;Takayuki Matsumae;Mio Taki;Sumio Saito;Norihiro Nishijima;Akihiro Nasu;Hideyuki Komekado;Ryuichi Kita;Toru Kimura;Osamu Arai;Yukio Osaki;Joo Yeon Jang;Ung Bae Jeon;Jin Hyeok Kim;Mingzhe Cai;Tara Gill;Chung Yip Chan;Pierce Chow;Xi Tai Winfred Goh;Sum Leong;Chow Wei Too;Zhuyi Rebekah Lee;Tze Shen Sean Ng;Hoau Gong;Richard Lo;Kiang Hiong Tay;Ju Min;Shaun Xavier Chan;Apoorva Gogna;Farah Gillan Irani;Nanda Kumar Karaddi Venkatanarasimha;Siu Hoong Kelvin Loke;Kah Hoe Pierce Chow;Chee Eng David Ng;Thijs August Johan Urlings;Ankur Patel;Karthikeyan Damodharan;Han Wei Luke Toh;Bien Soo Tan;Hyun Ju Kim;Jinhyun Choi;Sang Bong Ahn;Jinhong Jung;Sang Min Yoon;Hojin Kim;Byungchul Cho;Jungwon Kwak;Jong Hoon Kim;Sun Hyun Bae;Younghee Park;Chul Won Choi;Sunmi Jo;Yong Ho Kim;Bae-Kwon Jeong;Jin hee Kim;Woo Chul Kim;Jin Ho Kim;Won Il Jang;Mi-Sook Kim;Wen-Yen Huang;Cheng-Hsiang Lo;Yu-Ju Lin;Mei-Hsuan Lee;Chiao-Ling Tsai;Jason Chia-Hsien Cheng;Tae Hyung Kim;Soon Ho Um;Han Ah Lee;Jung Mi Chang;Dae Hoe Ku;Yeon Seok Seo;Sin Yu Yeung;Y.S. Tung;C.S. Wong;A.S. Lee;C.L. Chiang;Sherlynn Shi Ling Tan;David Ng;Sean Yan;Kelvin Loke;Richard Lo;Nanda Venkatanarasimha;Apoorva Gogna;Su Pin Choo;Han Chong Toh;David Tai;Brian Kim Poh Goh;Julianah Bal;Siew Huang Chua;Pierce Kah Hoe Chow;Dong Joon Oh;Young Nam Kim;Jin Dong Kim;Hana Park;Yun Bin Lee;Joo Ho Lee;Mi Na Kim;Young Eun Chon;Yeon Jung Ha;Seong Gyu Hwang;Kei Shibuya;Takanori Abe;Hiroyuki Katoh;Masahiko Okamoto;Ken Shirabe;Tatsuya Ohno;Takashi Nakano;Hyun Pyo Hong;Byung Ik Kim;Khin Maung Win;Khin Aye Wint Han;Soe Thiha Maung;Soe Tint;Si Thu Sein Win;Lin Thit Lwin;Win Thit Lwin;Su Su Htar;Aung Hlaing Bwa;Sang Jun Suh;Hyung Joon Yim;Dong Won Lee;Jong Jin Hyun;Young Kul Jung;Ji Hoon Kim;Yeon Seok Seo;Jong Eun Yeon;Kwan Soo Byun;Soon Ho Um;Gwang Hyeon Choi;Ju Hyun Shim;Jihyun An;Danbi Lee;Kang Mo Kim;Young-Suk Lim;Han Chu Lee;Young-Hwa Chung;Yung Sang Lee;Dong Jin Suh;Imelda Loho;Hye-Young Seo;Byoung Ku Jang;Mi-Kyung Kim;Jae Seok Hwang;So-Hee Lee;Yong-Han Paik;Sohn Won;Ju-Yeon Cho;Ji-Hoon Kim;Jung-IL Lee;Hyung Joon Kim;Min-Ah Woo;Sin-Ho Jung;Arun Iyer;Krishnadas Devdas;Santosh Yadav;Shahna Fathima;Gaurav Kapoor;Chethan Govindaraju;Srijaya Sreesh;Shanid Sathar;Aniruddha Singh;Young Kul Jung;Dae-ha Kim;Sang Jun Suh;Hyung Joon Yim;Ji Hoon Kim;Jong Eun Yeon;Kwan Soo Byun;Sun-Jae Lee;An Na Seo;Jae-Jun Shim;In-Seung Choi;Ye-Rin Lee;Ji Sung Lee;Byung-Ho Kim;In Hwan Oh;Hyung Joon Yim;Dong-won Lee;Yeon Seok Seo;Seong Kyun Na;Sang Jun Suh;Young Kul Jung;Ji Hoon Kim;Jong Eun Yeon;Soon Ho Um;Kwan Soo Byun;Ki Tae Suk;Dong Joon Kim;Ji Hwa Lee;Alexander Yip;Krishnakumar Madhavan;Alfred Kow;Wei Peng Yong;Karmarjit Singh Mangat;Daniel Huang;Kieron Lim;Seng Gee Lim;Yock Young Dan;Poh Seng Tan;Kian Leong Goh;Mihir Gandhi;Pierce Kah Hoe Chow;Jihyun An;Ha Il Kim;Seheon Chang;Jina Park;Danbi Lee;Kang Mo Kim;Young-Suk Lim;Han Chu Lee;Young-Hwa Chung;Yung Sang Lee;Ju Hyun Shim;Yue Sun Cheung;Paul Bo San Lai;Andree Kurniawan;Akhil Deepak Vatvani;Devita Widjaja;Kalis Waren;Moses Leonardo;Shih-Ting Huang;Tsang-En Wang;Jiunn-Chang Lin;Ching-Wei Chang;Shen-Yung Wang;Devita Widjaja;Akhil Vatvani;Kalis Waren;Moses Leonardo;Andree Kurniawan;Akhil Deepak Vatvani;Devita Widjaja;Kalis Waren;Moses Leonardo;Andree Kurniawan;Sojung Han;Beom Kyung Kim;Hye Won Lee;Jun Yong Park;Seung Up Kim;Do Young Kim;Sang Hoon Ahn;Jin-Sil Seong;Kwang-Hyub Han
- 期刊名称：《Liver Cancer》 | 2017年第Suppl 1期
3.Current Status on Cholangiocarcinoma and Gallbladder Cancer

机译：胆管癌和胆囊癌的现状
- 作者：Tomoki Ebata;Giorgio Ercolani;Domenico Alvaro;Dario Ribero;Luca Di Tommaso;Juan W. Valle
- 期刊名称：《Liver Cancer》 | 2016年第1期
4.Colorectal Liver Metastases: A Critical Review of State of the Art

机译：结直肠肝转移：最新研究进展
- 作者：Robert P Jones;Norihiro Kokudo;Gunnar Folprecht;Yoshihiro Mise;Michiaki Unno;Hassan Z Malik;Stephen W Fenwick;Graeme J Poston
- 期刊名称：《Liver Cancer》 | 2016年第1期
5.A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib

机译：Regorafenib和Lenvatinib联合治疗肝细胞癌的新时代
- 作者：Masatoshi Kudo
- 期刊名称：《Liver Cancer》 | 2017年第3期
6.Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases

机译：结直肠肝转移的化学疗法和外科手术的最新进展
- 作者：Guillaume Passot;Olivier Soubrane;Felice Giuliante;Giuseppe Zimmitti;Diane Goéré;Suguru Yamashita;Jean-Nicolas Vauthey
- 期刊名称：《Liver Cancer》 | 2016年第1期
7.Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm

机译：白蛋白-胆红素等级与肝细胞癌治疗算法
- 作者：Masatoshi Kudo
- 期刊名称：《Liver Cancer》 | 2017年第3期
8.Surgery of Colorectal Liver Metastases: Pushing the Limits

机译：大肠肝转移手术：突破极限
- 作者：Guido Torzilli;René Adam;Luca Viganò;Katsunori Imai;Jeremias Goransky;Andrea Fontana;Christian Toso;Pietro Majno;Eduardo de Santibañes
- 期刊名称：《Liver Cancer》 | 2016年第1期
9.How to Differentiate Borderline Hepatic Nodules in Hepatocarcinogenesis: Emphasis on Imaging Diagnosis

机译：在肝癌发生过程中如何区分边缘性肝结节：重视影像学诊断
- 作者：Hyun Jeong Park;Byung Ihn Choi;Eun Sun Lee;Sung Bin Park;Jong Beum Lee
- 期刊名称：《Liver Cancer》 | 2017年第3期
- Hepatocarcinogenesis Dysplastic nodule Hepatocellular carcinoma Imaging diagnosis Borderline nodule;
10.New Perspectives in the Treatment of Colorectal Metastases

机译：大肠转移治疗的新观点
- 作者：Dominique Elias;Luca Viganò;Franco Orsi;Marta Scorsetti;Tiziana Comito;Jan Lerut;Davide Cosola;Guido Torzilli
- 期刊名称：《Liver Cancer》 | 2016年第1期
11.Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications

机译：作为日本肝病学会HCC循证临床实践指南的一部分的白蛋白-胆红素（ALBI）等级：与肝损伤和Child-Pugh分类的比较
- 作者：Atsushi Hiraoka;Takashi Kumada;Masatoshi Kudo;Masashi Hirooka;Kunihiko Tsuji;Ei Itobayashi;Kazuya Kariyama;Toru Ishikawa;Kazuto Tajiri;Hironori Ochi;Toshifumi Tada;Hidenori Toyoda;Kazuhiro Nouso;Kouji Joko;Hideki Kawasaki;Yoichi Hiasa;Kojiro Michitaka
- 期刊名称：《Liver Cancer》 | 2017年第3期
- ALBI grade Indocyanine green Liver damage Child-Pugh Hepatocellular carcinoma;
12.Adoption of Sorafenib for the Treatment of Advanced-Stage Hepatocellular Carcinoma in Oncology Practices in the United States

机译：在美国的肿瘤学实践中采用索拉非尼治疗晚期肝细胞癌
- 作者：Helen M. Parsons;Quyen Chu;Jordan J. Karlitz;Jennifer L. Stevens;Linda C. Harlan
- 期刊名称：《Liver Cancer》 | 2017年第3期
- Hepatocellular carcinoma SEER Program Policy Treatment Sorafenib;
13.The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial Chemoembolization

机译：肝细胞癌患者的整体生存与经动脉化疗栓塞后新定义的进展时间相关
- 作者：Tadaaki Arizumi;Kazuomi Ueshima;Mina Iwanishi;Tomohiro Minami;Hirokazu Chishina;Masashi Kono;Masahiro Takita;Norihisa Yada;Satoru Hagiwara;Yasunori Minami;Hiroshi Ida;Yoriaki Komeda;Mamoru Takenaka;Toshiharu Sakurai;Tomohiro Watanabe;Naoshi Nishida;Masatoshi Kudo
- 期刊名称：《Liver Cancer》 | 2017年第3期
- Hepatocellular carcinoma Kinki criteria Overall survival Time to progression after transarterial chemoembolization Transarterial chemoembolization;
14.Beneficial Effect of Maintaining Hepatic Reserve during Chemotherapy on the Outcomes of Patients with Hepatocellular Carcinoma

机译：化疗期间维持肝储备对肝细胞癌患者结局的有益作用
- 作者：Takeshi Terashima;Tatsuya Yamashita;Kuniaki Arai;Kazunori Kawaguchi;Kazuya Kitamura;Taro Yamashita;Yoshio Sakai;Eishiro Mizukoshi;Masao Honda;Shuichi Kaneko
- 期刊名称：《Liver Cancer》 | 2017年第3期
- Hepatocellular carcinoma Hepatic reserve Child-Pugh score Hepatic arterial infusion chemotherapy Sorafenib;
15.Molecular Targeted Agents for Hepatocellular Carcinoma: Current Status and Future Perspectives

机译：肝细胞癌的分子靶向药物：现状和未来展望
- 作者：M. Kudo
- 期刊名称：《Liver Cancer》 | 2017年第2期
16.MicroRNAs for the Prediction of Early Response to Sorafenib Treatment in Human Hepatocellular Carcinoma

机译：MicroRNA在人类肝细胞癌中对索拉非尼治疗的早期反应预测。
- 作者：Naoshi Nishida;Tadaaki Arizumi;Satoru Hagiwara;Hiroshi Ida;Toshiharu Sakurai;Masatoshi Kudo
- 期刊名称：《Liver Cancer》 | 2017年第2期
17.Factors Influencing Surveillance for Hepatocellular Carcinoma in Patients with Liver Cirrhosis

机译：肝硬化患者肝癌监测的影响因素
- 作者：Hager A. Ahmed Mohammed;Ju Dong Yang;Nasra H. Giama;Jonggi Choi;Hawa M. Ali;Kristin C. Mara;William S. Harmsen;Russell H. Wiesner;Michael D. Leise;Terry M. Therneau;Lewis R. Roberts
- 期刊名称：《Liver Cancer》 | 2017年第2期
18.Short-Term Results of Laparoscopic Radiofrequency Ablation Using a Multipolar System for Localized Hepatocellular Carcinoma

机译：使用多极系统腹腔镜射频消融治疗局限性肝细胞癌的近期结果
- 作者：Naoki Morimoto;Norio Isoda;Yoshinari Takaoka;Takuya Hirosawa;Shunji Watanabe;Toshiya Otake;Kozue Murayama;Takeshi Fujieda;Mamiko Tsukui;Natsumi Miyata;Kohei Ono;Shota Yamaguchi;Hironori Yamamoto
- 期刊名称：《Liver Cancer》 | 2017年第2期
- Hepatocellular carcinoma Radiofrequency ablation Outcome Surgery Local ablation therapy;
19.Clinical Anatomy of the Liver: Review of the 19th Meeting of the Japanese Research Society of Clinical Anatomy

机译：肝脏的临床解剖学：日本临床解剖学研究学会第十九次会议综述
- 作者：Yoshihiro Sakamoto;Norihiro Kokudo;Yoshikuni Kawaguchi;Keiichi Akita
- 期刊名称：《Liver Cancer》 | 2017年第2期
20.Anatomical Study of the Caudate Lobe with Special Reference to Portal Venous and Biliary Branches Using Corrosion Liver Casts and Clinical Application

机译：使用腐蚀型肝铸件对尾状叶的解剖学研究特别是对门静脉和胆道分支的参考及临床应用
- 作者：Masamitsu Kumon
- 期刊名称：《Liver Cancer》 | 2017年第2期
- Corrosion liver casts Liver segments Anatomy of the liver Liver surgery Biliary surgery;
21.Commentary on the Paper Anatomical Study of the Caudate Lobe with Special Reference to the Portal Venous and Biliary Branches Using Corrosion Liver Casts and Clinical Application by Kumon

机译：Kumon对论文使用腐蚀的肝铸件对尾状叶的解剖学研究特别是对门静脉和胆道分支的解剖学及其临床应用的评论
- 作者：Guido Torzilli
- 期刊名称：《Liver Cancer》 | 2017年第2期
22.Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan United States and Europe

机译：日本美国和欧洲之间的肝细胞癌临床实践指南差异
- 期刊名称：《Liver Cancer》 | 2015年第2期
23.Phase I Trial of Sorafenib Following Liver Transplantation in Patients with High-Risk Hepatocellular Carcinoma

机译：高风险肝细胞癌患者肝移植后索拉非尼的I期试验
- 作者：Abby B. Siegel;Anthony B. El-Khoueiry;Richard S. Finn;Katherine A. Guthrie;Abhishek Goyal;Alan P. Venook;Charles D. Blanke;Elizabeth C. Verna;Lorna Dove;Jean Emond;Tomoaki Kato;Benjamin Samstein;Ronald Busuttil;Helen Remotti;Amy Coffey;Robert S. Brown Jr
- 期刊名称：《Liver Cancer》 | 2015年第2期
24.Imaging Modalities for Assessment of Treatment Response to Nonsurgical Hepatocellular Carcinoma Therapy: Contrast-Enhanced US CT and MRI

机译：评估非手术性肝细胞癌治疗反应的影像学方法：对比增强的USCT和MRI
- 作者：Yasunori Minami;Masatoshi Kudo
- 期刊名称：《Liver Cancer》 | 2015年第2期
25.Tumor Markers for Hepatocellular Carcinoma: Simple and Significant Predictors of Outcome in Patients with HCC

机译：肝细胞癌的肿瘤标志物：HCC患者结果的简单和重要预测因子
- 作者：Hidenori Toyoda;Takashi Kumada;Toshifumi Tada;Yasuhiro Sone;Yuji Kaneoka;Atsuyuki Maeda
- 期刊名称：《Liver Cancer》 | 2015年第2期
26.Heterogeneity and Subclassification of Barcelona Clinic Liver Cancer Stage B

机译：巴塞罗那临床肝癌B期的异质性和亚分类
- 作者：M. Kudo
- 期刊名称：《Liver Cancer》 | 2016年第2期
27.National Cancer Centre Singapore Consensus Guidelines for Hepatocellular Carcinoma

机译：新加坡国家癌症中心肝细胞癌共识指南
- 作者：Pierce K. H. Chow;Su Pin Choo;David C. E. Ng;Richard H. G. Lo;Michael L. C. Wang;Han Chong Toh;David W. M. Tai;Brian K. P. Goh;Jen San Wong;Kiang Hiong Tay;Anthony S. W. Goh;Sean X. Yan;Kelvin S. H. Loke;Sue Ping Thang;Apoorva Gogna;Chow Wei Too;Farah Gillian Irani;Sum Leong;Kiat Hon Lim;Choon Hua Thng
- 期刊名称：《Liver Cancer》 | 2016年第2期
- Diagnosis Hepatocellular carcinoma Practice guidelines Radiation therapy Surgery;
28.Outcomes of Hepatic Resection in Intrahepatic Cholangiocarcinoma Patients with Diabetes Hypertension and Dyslipidemia: Significance of Routine Follow-Up

机译：肝内胆管癌合并糖尿病高血压和血脂异常患者的肝切除结果：常规随访的意义
- 作者：Takayoshi Nishioka;Shoji Kubo;Shogo Tanaka;Kenichi Wakasa;Shigekazu Takemura;Masahiko Kinoshita;Genya Hamano;Yuko Kuwae;Toshihiko Shibata;Shigefumi Suehiro
- 期刊名称：《Liver Cancer》 | 2016年第2期
- Follow-up Intrahepatic cholangiocarcinoma Metabolic Non-alcoholic fatty liver disease;
29.Selection Criteria and Current Issues in Liver Transplantation for Hepatocellular Carcinoma

机译：肝细胞癌肝移植的选择标准和当前问题
- 作者：Toshimi Kaido
- 期刊名称：《Liver Cancer》 | 2016年第2期
- Direct-acting antiviral agents Expanded criteria Hepatocellular carcinoma Liver transplantation Sarcopenia;
30.Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges

机译：肝细胞癌的肿瘤异质性：面临的挑战
- 作者：Li-Chun Lu;Chih-Hung Hsu;Chiun Hsu;Ann-Lii Cheng
- 期刊名称：《Liver Cancer》 | 2016年第2期
- Circulating tumor cell Circulating tumor DNA Clonality Hepatocellular carcinoma Tumor heterogeneity;
31.Optimal Selection of Radiotherapy as Part of a Multimodal Approach for Hepatocellular Carcinoma

机译：放射治疗的最佳选择作为肝细胞癌多模式方法的一部分
- 作者：Hong In Yoon;Jinsil Seong
- 期刊名称：《Liver Cancer》 | 2016年第2期
- Hepatocellular carcinoma Multimodal approach Radiotherapy;
32.Extremely High Objective Response Rate of Lenvatinib: Its Clinical Relevance and Changing the Treatment Paradigm in Hepatocellular Carcinoma

机译：Lenvatinib的极高客观反应率：其临床意义和改变肝细胞癌的治疗范例
- 作者：Masatoshi Kudo
- 期刊名称：《Liver Cancer》 | 2018年第3期
33.Lenvatinib in Advanced Hepatocellular Carcinoma

机译：Lenvatinib在晚期肝细胞癌中
- 作者：Masatoshi Kudo
- 期刊名称：《Liver Cancer》 | 2017年第4期
34.Proposal of Primary Endpoints for TACE Combination Trials with Systemic Therapy: Lessons Learned from 5 Negative Trials and the Positive TACTICS Trial

机译：TACE联合试验与系统治疗的主要终点的建议：从5个阴性试验和TACTICS阳性试验中吸取的教训
- 作者：Masatoshi Kudo
- 期刊名称：《Liver Cancer》 | 2018年第3期
35.Consensus on Stereotactic Body Radiation Therapy for Small-Sized Hepatocellular Carcinoma at the 7th Asia-Pacific Primary Liver Cancer Expert Meeting

机译：在第七届亚太原发性肝癌专家会议上对小型肝细胞癌的立体定向放射疗法达成共识
- 作者：Zhao-Chong Zeng;Jinsil Seong;Sang Min Yoon;Jason Chia-Hsien Cheng;Ka-On Lam;Ann-Shing Lee;Ada Law;Jian-Ying Zhang;Yong Hu
- 期刊名称：《Liver Cancer》 | 2017年第4期
- Hepatocellular carcinoma Stereotactic body radiation therapy Survival Radiation-induced liver disease;
36.Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)

机译：中国原发性肝癌诊治指南（2017年版）
- 作者：Jian Zhou;Hui-Chuan Sun;Zheng Wang;Wen-Ming Cong;Jian-Hua Wang;Meng-Su Zeng;Jia-Mei Yang;Ping Bie;Lian-Xin Liu;Tian-Fu Wen;Guo-Hong Han;Mao-Qiang Wang;Rui-Bao Liu;Li-Gong Lu;Zheng-Gang Ren;Min-Shan Chen;Zhao-Chong Zeng;Ping Liang;Chang-Hong Liang;Min Chen;Fu-Hua Yan;Wen-Ping Wang;Yuan Ji;Wen-Wu Cheng;Chao-Liu Dai;Wei-Dong Jia;Ya-Ming Li;Ye-Xiong Li;Jun Liang;Tian-Shu Liu;Guo-Yue Lv;Yi-Lei Mao;Wei-Xin Ren;Hong-Cheng Shi;Wen-Tao Wang;Xiao-Ying Wang;Bao-Cai Xing;Jian-Ming Xu;Jian-Yong Yang;Ye-Fa Yang;Sheng-Long Ye;Zheng-Yu Yin;Bo-Heng Zhang;Shui-Jun Zhang;Wei-Ping Zhou;Ji-Ye Zhu;Rong Liu;Ying-Hong Shi;Yong-Sheng Xiao;Zhi Dai;Gao-Jun Teng;Jian-Qiang Cai;Wei-Lin Wang;Jia-Hong Dong;Qiang Li;Feng Shen;Shu-Kui Qin;Jia Fan
- 期刊名称：《Liver Cancer》 | 2018年第3期
- Cancer Carcinoma China Liver Diagnosis Treatment;
37.Sorafenib versus Hepatic Arterial Infusion Chemotherapy as Initial Treatment for Hepatocellular Carcinoma with Advanced Portal Vein Tumor Thrombosis

机译：索拉非尼与肝动脉灌注化疗作为晚期门静脉肿瘤血栓形成的肝细胞癌的初始治疗
- 作者：Michihisa Moriguchi;Takeshi Aramaki;Hideyuki Nishiofuku;Rui Sato;Koiku Asakura;Kanji Yamaguchi;Toshihiro Tanaka;Masahiro Endo;Yoshito Itoh
- 期刊名称：《Liver Cancer》 | 2017年第4期
- Hepatic arterial infusion chemotherapy Hepatocellular carcinoma Low-dose 5-fluorouracil and cisplatin Portal vein tumor thrombus Sorafenib;
38.Long-Term Prognostic Factors after Hepatic Resection for Hepatitis C Virus-Related Hepatocellular Carcinoma with a Special Reference to Viral Status

机译：丙型肝炎病毒相关肝细胞癌肝切除术后的长期预后因素特别是对病毒状态的参考
- 作者：Masaki Koda;Shogo Tanaka;Shigekazu Takemura;Hiroji Shinkawa;Masahiko Kinoshita;Genya Hamano;Tokuji Ito;Norifumi Kawada;Toshihiko Shibata;Shoji Kubo
- 期刊名称：《Liver Cancer》 | 2018年第3期
- Hepatocellular carcinoma Hepatitis C Interferon Surgery Sustained virological response;
39.An Ecological Study of the Association between Air Pollution and Hepatocellular Carcinoma Incidence in Texas

机译：德克萨斯州空气污染与肝细胞癌发病率关联的生态研究
- 作者：Luca Cicalese;Loren Raun;Ali Shirafkan;Laura Campos;Daria Zorzi;Mauro Montalbano;Colin Rhoads;Valia Gazis;Katherine Ensor;Cristiana Rastellini
- 期刊名称：《Liver Cancer》 | 2017年第4期
- Liver cancer Hepatocellular carcinoma Public health Air pollutants Risk factors;
40.Immune Gene Expression Profile in Hepatocellular Carcinoma and Surrounding Tissue Predicts Time to Tumor Recurrence

机译：肝细胞癌及周围组织中的免疫基因表达谱预测肿瘤复发的时间
- 作者：Chiara Carone;Andrea Olivani;Raffaele Dalla Valle;Roberta Manuguerra;Enrico Maria Silini;Tommaso Trenti;Gabriele Missale;Elisabetta Cariani
- 期刊名称：《Liver Cancer》 | 2018年第3期
- Hepatocellular carcinoma Immune microenvironment T lymphocytes Recurrence Prognosis;
41.Clinical Factors Predicting Better Survival Outcome for Pulmonary Metastasectomy of Hepatocellular Carcinoma

机译：预测肝细胞癌肺转移切除术生存期更好的临床因素
- 作者：Tse-Ming Kuo;Kai-Ming Chang;Tsun-I Cheng;Kuo-Jang Kao
- 期刊名称：《Liver Cancer》 | 2017年第4期
- Extrahepatic metastasis Hepatocellular carcinoma Outcome Prognosis prediction Surgery;
42.Vinyl Institute Comments on Cicalese et al.: An Ecological Study of the Association between Air Pollution and Hepatocellular Carcinoma Incidence in Texas

机译：乙烯基研究所对Cicalese等人的评论：德克萨斯州空气污染与肝细胞癌发病率之间关系的生态研究
- 作者：Richard Krock
- 期刊名称：《Liver Cancer》 | 2018年第3期
43.Association of Serum Ferritin with Diabetes and Alcohol in Patients with Non-Viral Liver Disease-Related Hepatocellular Carcinoma

机译：非病毒性肝病相关肝细胞癌患者血清铁蛋白与糖尿病和酒精的关系
- 作者：Rohan C. Siriwardana;Madunil A. Niriella;Anuradha Dassanayake;Dileepa Ediriweera;Bhagya Gunetilleke;Thenuka Sivasundaram;Janaka de Silva
- 期刊名称：《Liver Cancer》 | 2017年第4期
- Hepatocellular carcinoma diagnosis;
- Hepatocellular carcinoma etiology;
- Blood;
- Ferritin;
44.European Council of Vinyl Manufacturers Comments on Cicalese et al.: An Ecological Study of the Association between Air Pollution and Hepatocellular Carcinoma Incidence in Texas

机译：欧洲乙烯基制造商理事会对Cicalese等人的评论：德克萨斯州空气污染与肝细胞癌发病率之间关系的生态研究
- 作者：Ariane Gennissen;Marc Boeckx;Arjen Sevenster
- 期刊名称：《Liver Cancer》 | 2018年第3期
45.Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study

机译：治疗阶段迁移可最大程度提高索拉非尼治疗的肝细胞癌患者的生存率：一项观察性研究
- 作者：Clarence Yen;Rohini Sharma;Lorenza Rimassa;Tadaaki Arizumi;Dominik Bettinger;Huay Yee Choo;Tiziana Pressiani;Michela E. Burlone;Mario Pirisi;Laura Giordano;Anisa Abdulrahman;Masatoshi Kudo;Robert Thimme;Joong Won Park;David James Pinato
- 期刊名称：《Liver Cancer》 | 2017年第4期
- Hepatocellular carcinoma Sorafenib Treatment stage migration Prognosis Treatment-naïve patients;
46.Methodological Limitations to the Analysis by Cicalese et al.

机译：Cicalese等人的分析方法学局限性。
- 作者：Gary M. Marsh;Kevin M. Towle
- 期刊名称：《Liver Cancer》 | 2018年第3期
47.Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function

机译：在日本对46681例肝细胞癌患者进行的全国性调查中白蛋白-胆红素等级和预后的验证和潜力：需要更详细的肝功能评估
- 作者：Atsushi Hiraoka;Kojiro Michitaka;Takashi Kumada;Namiki Izumi;Masumi Kadoya;Norihiro Kokudo;Shoji Kubo;Yutaka Matsuyama;Osamu Nakashima;Michiie Sakamoto;Tadatoshi Takayama;Takashi Kokudo;Kosuke Kashiwabara;Masatoshi Kudo
- 期刊名称：《Liver Cancer》 | 2017年第4期
- Hepatocellular carcinoma Albumin-bilirubin grade TNM stage Japan Integrated Staging Prognosis Modified albumin-bilirubin grade;
48.Response to the Comments on Cicalese et al.: An Ecological Study of the Association between Air Pollution and Hepatocellular Carcinoma Incidence in Texas

机译：对Cicalese等人的评论的回应：德克萨斯州空气污染与肝细胞癌发病率之间关系的生态研究
- 作者：Loren Raun;Ali Shirafkan;Laura Campos;Daria Zorzi;Mauro Montalbano;Colin Rhoads;Valia Gazis;Katherine Ensor;Cristiana Rastellini;Luca Cicalese
- 期刊名称：《Liver Cancer》 | 2018年第3期
49.Efficacy and Safety of Systemic Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis of Phase III Trials

机译：晚期肝细胞癌全身治疗的疗效和安全性：III期临床试验的网络荟萃分析
- 作者：Alessandro Cucchetti;Fabio Piscaglia;Antonio Daniele Pinna;Benjamin Djulbegovic;Federico Mazzotti;Luigi Bolondi
- 期刊名称：《Liver Cancer》 | 2017年第4期
- Hepatocellular carcinoma Systemic therapy Sorafenib Network meta-analysis Safety Survival;
50.Erratum

机译：勘误表
- 期刊名称：《Liver Cancer》 | 2018年第3期
51.Prospective Comparison of Gd-EOB-DTPA-Enhanced MRI with Dynamic CT for Detecting Recurrence of HCC after Radiofrequency Ablation

机译：Gd-EOB-DTPA增强MRI与动态CT在射频消融后检测HCC复发的前瞻性比较
- 作者：Yasuharu Imai;Kazuhiro Katayama;Masatoshi Hori;Takayuki Yakushijin;Kenji Fujimoto;Toshifumi Itoh;Takumi Igura;Mitsuru Sakakibara;Manabu Takamura;Masakatsu Tsurusaki;Hiroto Takahashi;Katsuyuki Nakanishi;Noriaki Usuki;Koh Tsuji;Hiroshi Ohashi;Tonsok Kim;Tetsuo Takehara;Takamichi Murakami
- 期刊名称：《Liver Cancer》 | 2017年第4期
- Hepatocellular carcinoma Radiofrequency ablation Gd-EOB-DTPA-MRI Computed tomography Recurrence;
52.Hepatocellular Carcinoma with Macrovascular Invasion: Defining the Optimal Treatment Strategy

机译：伴大血管浸润的肝细胞癌：定义最佳治疗策略
- 作者：Charlotte E. Costentin;Cristina R. Ferrone;Ronald S. Arellano;Suvranu Ganguli;Theodore S. Hong;Andrew X. Zhu
- 期刊名称：《Liver Cancer》 | 2017年第4期
- Hepatocellular carcinoma Macrovascular invasion Sorafenib alternatives;
53.ALBI Score as a Novel Tool in Staging and Treatment Planning for Hepatocellular Carcinoma: Is It Sufficient?

机译：ALBI评分是肝细胞癌分期和治疗计划中的一种新颖工具：足够吗？
- 作者：Teh-Ia Huo;Po-Hong Liu;Chia-Yang Hsu
- 期刊名称：《Liver Cancer》 | 2017年第4期
54.ALBI Score as a Novel Tool in Staging and Treatment Planning for Hepatocellular Carcinoma: Advantage of ALBI Grade for Universal Assessment of Hepatic Function

机译：ALBI评分作为肝细胞癌分期和治疗计划中的一种新型工具：ALBI等级在肝功能通用评估中的优势
- 作者：Atsushi Hiraoka;Kojiro Michitaka;Takashi Kumada;Masashi Kudo
- 期刊名称：《Liver Cancer》 | 2017年第4期
55.Ramucirumab as Second-Line Systemic Therapy in Hepatocellular Carcinoma

机译：雷米库单抗作为肝细胞癌的二线全身治疗
- 作者：Masatoshi Kudo
- 期刊名称：《Liver Cancer》 | 2018年第4期
56.Effectiveness of Particle Radiotherapy in Various Stages of Hepatocellular Carcinoma: A Pilot Study

机译：粒子放射疗法在肝细胞癌各个阶段的有效性：一项初步研究
- 作者：Yushi Sorin;Kenji Ikeda;Yusuke Kawamura;Shunichiro Fujiyama;Masahiro Kobayashi;Tetsuya Hosaka;Hitomi Sezaki;Norio Akuta;Satoshi Saitoh;Fumitaka Suzuki;Yoshiyuki Suzuki;Yasuji Arase;Hiromitsu Kumada
- 期刊名称：《Liver Cancer》 | 2018年第4期
- Carbon ion Hepatocellular carcinoma Local control Particle radiotherapy Proton beam;
57.The Prognosis of Single Large Hepatocellular Carcinoma Was Distinct from Barcelona Clinic Liver Cancer Stage A or B: The Role of Albumin-Bilirubin Grade

机译：巴塞罗那大型临床肝癌A期或B期的单个大肝细胞癌预后不同：白蛋白-胆红素等级的作用
- 作者：Kuan-Chieh Fang;Wei-Yu Kao;Chien-Wei Su;Po-Chun Chen;Pei-Chang Lee;Yi-Hsiang Huang;Teh-Ia Huo;Chun-Chao Chang;Ming-Chih Hou;Han-Chieh Lin;Jaw-Ching Wu
- 期刊名称：《Liver Cancer》 | 2018年第4期
- Barcelona Clinic Liver Cancer stage Hepatocellular carcinoma Prognosis Staging Tumor size;
58.No Muscle Depletion with High Visceral Fat as a Novel Beneficial Biomarker of Sorafenib for Hepatocellular Carcinoma

机译：高肌肉脂肪无肌肉衰竭作为索拉非尼治疗肝细胞癌的新型有益生物标志物
- 作者：Issei Saeki;Takahiro Yamasaki;Masaki Maeda;Reo Kawano;Takuro Hisanaga;Takuya Iwamoto;Toshihiko Matsumoto;Isao Hidaka;Tsuyoshi Ishikawa;Taro Takami;Isao Sakaida
- 期刊名称：《Liver Cancer》 | 2018年第4期
- Body composition Hepatocellular carcinoma No muscle depletion Sorafenib Visceral fat area;
59.Defect Reperfusion Imaging with Sonazoid®: A Breakthrough in Hepatocellular Carcinoma

机译：Sonazoid®的缺损再灌注成像：肝细胞癌的突破
- 作者：M. Kudo
- 期刊名称：《Liver Cancer》 | 2016年第1期
60.Breakthrough Imaging in Hepatocellular Carcinoma

机译：肝细胞癌的突破性成像
- 作者：M. Kudo
- 期刊名称：《Liver Cancer》 | 2016年第1期
61.Prediction of Hepatocellular Carcinoma Incidence Risk by Ultrasound Elastography

机译：超声弹性成像预测肝细胞癌的发病风险
- 作者：M. Kudo
- 期刊名称：《Liver Cancer》 | 2014年第1期
62.The Effectiveness of Multiple Electrode Radiofrequency Ablation in Patients with Hepatocellular Carcinoma with Lesions More than 3 cm in Size and Barcelona Clinic Liver Cancer Stage A to B2

机译：多电极射频消融术对肝癌尺寸大于3 cm的病变以及巴塞罗那临床肝癌A至B2期的疗效
- 作者：Chen-Chun Lin;Ya-Ting Cheng;Wei-Ting Chen M;Shi-Ming Lin
- 期刊名称：《Liver Cancer》 | 2016年第1期
63.The Beginning of a New Era of Digestive Surgery Guided by Fluorescence Imaging

机译：荧光成像指导的消化外科新时代的开始
- 作者：Takeaki Ishizawa;Norihiro Kokudo
- 期刊名称：《Liver Cancer》 | 2014年第1期
64.Clinical Characteristics of Patients with Cryptogenic Hepatocellular Carcinoma in a Hepatitis B Virus-Endemic Area

机译：乙型肝炎病毒流行地区隐源性肝细胞癌患者的临床特征
- 作者：Hee-Won Kwak;Joong-Won Park;Young Hwan Koh;Ju Hee Lee;Ami Yu;Byung-Ho Nam
- 期刊名称：《Liver Cancer》 | 2016年第1期
65.Clinical Trials of Combined Molecular Targeted Therapy and Locoregional Therapy in Hepatocellular Carcinoma: Past Present and Future

机译：肝细胞癌分子靶向治疗与局部区域治疗相结合的临床试验：过去现在和未来
- 作者：Hwi Young Kim;Joong-Won Park
- 期刊名称：《Liver Cancer》 | 2014年第1期
66.Use of Transarterial Chemoembolization (TACE) and Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: US Regional Analysis of the GIDEON Registry

机译：在无法切除的肝细胞癌患者中使用经动脉化学栓塞（TACE）和索拉非尼：美国对GIDEON注册表的区域分析
- 作者：Jean-Francois H. Geschwind;Pierre M. Gholam;Alec Goldenberg;Parvez Mantry;Robert C. G. Martin;Bilal Piperdi;Ellen Zigmont;Joanne Imperial;Svetlana Babajanyan;Pamela K. Foreman;Allen Cohn
- 期刊名称：《Liver Cancer》 | 2016年第1期
67.Radiotherapeutic Options for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

机译：肝细胞癌合并门静脉肿瘤血栓形成的放射治疗选择
- 作者：Dong Soo Lee;Jinsil Seong
- 期刊名称：《Liver Cancer》 | 2014年第1期
68.Imaging Diagnosis of Hepatocellular Carcinoma: Recent Advances of Contrast-Enhanced Ultrasonography with SonoVue®

机译：肝细胞癌的影像诊断：SonoVue®超声造影增强技术的最新进展
- 作者：Veronica Salvatore;Alice Gianstefani;Giulia Negrini;Giulia Allegretti;Marzia Galassi;Fabio Piscaglia
- 期刊名称：《Liver Cancer》 | 2016年第1期
69.Recent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRI

机译：肝细胞癌影像学诊断的最新进展：牛ado酸增强MRI的价值
- 作者：Ijin Joo;Jeong Min Lee
- 期刊名称：《Liver Cancer》 | 2016年第1期
70.Quantitative Levels of Hepatitis B Virus DNA and Surface Antigen and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy

机译：接受长期核苷类疗法的乙型肝炎患者乙型肝炎病毒DNA和表面抗原的定量水平和肝细胞癌的风险
- 作者：Miwa Kawanaka;Ken Nishino;Jun Nakamura;Takahito Oka;Noriyo Urata;Daisuke Goto;Mitsuhiko Suehiro;Hirofumi Kawamoto;Masatoshi Kudo;Gotaro Yamada
- 期刊名称：《Liver Cancer》 | 2014年第1期
71.Tracking Navigation Imaging of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Using Three-Dimensional Cone-Beam CT Angiography

机译：三维锥形束CT血管造影术对肝癌行经导管动脉化疗栓塞的跟踪导航成像
- 作者：Yasunori Minami;Yukinobu Yagyu;Takamichi Murakami;Masatoshi Kudo
- 期刊名称：《Liver Cancer》 | 2014年第1期
72.Lenvatinib May Drastically Change the Treatment Landscape of Hepatocellular Carcinoma

机译：Lenvatinib可能会彻底改变肝细胞癌的治疗格局
- 作者：Masatoshi Kudo
- 期刊名称：《Liver Cancer》 | 2018年第1期
73.Combination Cancer Immunotherapy in Hepatocellular Carcinoma

机译：肝细胞癌的联合癌症免疫治疗
- 作者：Masatoshi Kudo
- 期刊名称：《Liver Cancer》 | 2018年第1期
74.Short-Term Outcomes following Hepatectomy in Elderly Patients with Hepatocellular Carcinoma: An Analysis of 10805 Septuagenarians and 2381 Octo- and Nonagenarians in Japan

机译：老年肝细胞癌患者肝切除术后的短期结果：对日本10805趾骨nar人和2381八角和非age人的分析
- 作者：Hiroko Okinaga;Hideo Yasunaga;Kiyoshi Hasegawa;Kiyohide Fushimi;Norihiro Kokudo
- 期刊名称：《Liver Cancer》 | 2018年第1期
- Hepatocellular carcinoma Octo-onagenarians Super elderly Surgery;
75.Liver Stiffness Measured by Two-Dimensional Shear-Wave Elastography: Prognostic Value after Radiofrequency Ablation for Hepatocellular Carcinoma

机译：二维剪切波弹性成像技术测量肝硬度：射频消融治疗肝细胞癌的预后价值
- 作者：Dong Ho Lee;Jeong Min Lee;Jung-Hwan Yoon;Yoon Jun Kim;Jeong-Hoon Lee;Su Jong Yu;Joon Koo Han
- 期刊名称：《Liver Cancer》 | 2018年第1期
- Hepatocellular carcinoma Radiofrequency ablation Overall survival Two-dimensional supersonic shear-wave elastography Liver stiffness measurement;
76.Preoperative Low Muscle Mass and Low Muscle Quality Negatively Impact on Pulmonary Function in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma

机译：术前低肌肉质量和低肌肉质量对肝细胞癌肝切除术患者肺功能的负面影响
- 作者：Hisaya Shirai;Toshimi Kaido;Yuhei Hamaguchi;Atsushi Kobayashi;Shinya Okumura;Siyuan Yao;Shintaro Yagi;Naoko Kamo;Kojiro Taura;Hideaki Okajima;Shinji Uemoto
- 期刊名称：《Liver Cancer》 | 2018年第1期
- Sarcopenia Cardiac function Pulmonary function Hepatocellular carcinoma Psoas muscle index Intramuscular adipose tissue content;
77.Association between Loss of Skeletal Muscle Mass and Mortality and Tumor Recurrence in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

机译：肝细胞癌的骨骼肌质量丧失与死亡率和肿瘤复发之间的关联：系统评价和荟萃分析
- 作者：Ke-Vin Chang;Jin-De Chen;Wei-Ting Wu;Kuo-Chin Huang;Chia-Tzu Hsu;Der-Sheng Han
- 期刊名称：《Liver Cancer》 | 2018年第1期
- Cancer Hepatocellular carcinoma Muscle mass Sarcopenia Survival;
78.Patient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment

机译：肝细胞癌经动脉化疗栓塞的患者选择：获益/风险评估的重要性
- 作者：Fabio Piscaglia;Sadahisa Ogasawara
- 期刊名称：《Liver Cancer》 | 2018年第1期
- Hepatocellular carcinoma Regorafenib Sorafenib Transarterial chemoembolization;
79.Cabozantinib as a Second-Line Agent in Advanced Hepatocellular Carcinoma

机译：卡博替尼作为晚期肝细胞癌的二线药物
- 作者：Masatoshi Kudo
- 期刊名称：《Liver Cancer》 | 2018年第2期
80.Management of Hepatocellular Carcinoma in Japan as a World-Leading Model

机译：以世界领先的模式管理日本的肝细胞癌
- 作者：Masatoshi Kudo
- 期刊名称：《Liver Cancer》 | 2018年第2期
81.Regional Differences in Efficacy Safety and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II Study

机译：晚期肝细胞癌患者二线阿昔替尼的疗效安全性和生物标志物的区域差异：来自一项随机II期研究
- 作者：Masatoshi Kudo;Yoon-Koo Kang;Joong-Won Park;Shukui Qin;Yoshitaka Inaba;Eric Assenat;Yoshiko Umeyama;Maria José Lechuga;Olga Valota;Yosuke Fujii;Jean-Francois Martini;J. Andrew Williams;Shuntaro Obi
- 期刊名称：《Liver Cancer》 | 2018年第2期
- Asian Axitinib Biomarkers Hepatocellular carcinoma MicroRNAs;
82.A Phase I/Randomized Phase II Study to Evaluate the Safety Pharmacokinetics and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma

机译：I期/随机化II期研究评估Nintedanib与Sorafenib在亚洲晚期肝细胞癌患者中的安全性药代动力学和疗效
- 作者：Chia-Jui Yen;Tae-You Kim;Yin-Hsun Feng;Yee Chao;Deng-Yn Lin;Baek-Yeol Ryoo;Dennis Chin-Lun Huang;David Schnell;Julia Hocke;Arsène-Bienvenu Loembé;Ann-Lii Cheng
- 期刊名称：《Liver Cancer》 | 2018年第2期
- Nintedanib Sorafenib Advanced hepatocellular carcinoma Angiokinase inhibitor Dose-limiting toxicity Maximum tolerated dose;
83.Liver Transplantation for Intermediate-Stage Hepatocellular Carcinoma

机译：肝移植治疗中级肝细胞癌
- 作者：Naoko Kamo;Toshimi Kaido;Shintaro Yagi;Hideaki Okajima;Shinji Uemoto
- 期刊名称：《Liver Cancer》 | 2018年第2期
- Intermediate-stage hepatocellular carcinoma Kyoto criteria Pretreatment Transarterial chemoembolization Transplantation;
84.Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals

机译：用直接作用抗病毒药进行HCV治疗后从头发生肝细胞癌的风险
- 作者：Fabian Finkelmeier;Georg Dultz;Kai-Henrik Peiffer;Bernd Kronenberger;Franziska Krauss;Stefan Zeuzem;Christoph Sarrazin;Johannes Vermehren;Oliver Waidmann
- 期刊名称：《Liver Cancer》 | 2018年第2期
- Hepatitis C Hepatocellular carcinoma Direct-acting antivirals;
85.Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure

机译：成功治疗晚期肝细胞癌并即将发生肝衰竭的患者成功进行肝动脉灌注
- 作者：Tsung-Hao Liu;Chih-Hung Hsu;Yu-Yun Shao
- 期刊名称：《Liver Cancer》 | 2018年第2期
86.Hepatic Arterial Infusion Chemotherapy: A Potential Therapeutic Option for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

机译：肝动脉灌注化疗：门静脉肿瘤血栓形成的肝细胞癌的潜在治疗选择。
- 作者：Michihisa Moriguchi;Takeshi Aramaki;Toshihiro Tanaka;Yoshito Itoh
- 期刊名称：《Liver Cancer》 | 2018年第2期
87.Erratum

机译：勘误表
- 期刊名称：《Liver Cancer》 | 2019年第1期
88.Erratum

机译：勘误表
- 期刊名称：《Liver Cancer》 | 2019年第4期
89.A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination Therapy

机译：肝细胞癌全身治疗的新纪元：Atezolizumab联合贝伐单抗联合治疗
- 作者：Masatoshi Kudo
- 期刊名称：《Liver Cancer》 | 2020年第2期
90.Comparison of Partial Hepatectomy and Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

机译：中年肝细胞癌部分肝切除和经动脉化疗栓塞的比较：系统评价和荟萃分析
- 作者：Ismail Labgaa;Patrick Taffé;David Martin;Daniel Clerc;Myron Schwartz;Norihiro Kokudo;Alban Denys;Nermin Halkic;Nicolas Demartines;Emmanuel Melloul
- 期刊名称：《Liver Cancer》 | 2020年第2期
- Liver cancer;
- Barcelona Clinic Liver Cancer;
- Resection;
- Surgery;
- Transarterial chemoembolization;
- Loco-regional therapy;
91.Skeletal Muscle Loss during Tyrosine Kinase Inhibitor Treatment for Advanced Hepatocellular Carcinoma Patients

机译：酪氨酸激酶抑制剂治疗晚期肝细胞癌患者期间的骨骼肌丢失
- 作者：Shinsuke Uchikawa;Tomokazu Kawaoka;Maiko Namba;Kenichiro Kodama;Kazuki Ohya;Kei Morio;Takashi Nakahara;Eisuke Murakami;Masataka Tsuge;Akira Hiramatsu;Michio Imamura;Shoichi Takahashi;Kazuaki Chayama;Hiroshi Aikata
- 期刊名称：《Liver Cancer》 | 2020年第2期
- Skeletal muscle;
- Hepatocellular carcinoma;
- Tyrosine kinase inhibitor;
- Sorafenib;
- Lenvatinib;
92.Microvascular Invasion and a Size Cutoff Value of 2 cm Predict Long-Term Oncological Outcome in Multiple Hepatocellular Carcinoma: Reappraisal of the American Joint Committee on Cancer Staging System and Validation Using the Surveillance Epidemiology and End-Results Database

机译：微血管浸润和2 cm的大小截断值可预测多发性肝细胞癌的长期肿瘤学结果：美国联合分期癌症分期委员会的重新评估以及使用监测流行病学和最终结果数据库的验证
- 作者：Junichi Shindoh;Yuta Kobayashi;Yusuke Kawamura;Norio Akuta;Masahiro Kobayashi;Yoshiyuki Suzuki;Kenji Ikeda;Masaji Hashimoto
- 期刊名称：《Liver Cancer》 | 2020年第2期
- Hepatocellular carcinoma;
- Surgery;
- Prognostic prediction;
- Staging system;
93.Development of a Novel Inflammation-Based Index for Hepatocellular Carcinoma

机译：新型基于炎症的肝细胞癌指标的建立
- 作者：Stephen Lam Chan;Lin-Lee Wong;Kwan-Chee Allen Chan;Chit Chow;Joanna Hung-Man Tong;Terry Cheuk-Fung Yip;Grace Lai-Hung Wong;Charing Ching-Ning Chong;Po-Hong Liu;Cheuk-Man Chu;Vincent Wai-Sun Wong;Ka-Fai To;Helen L. Reeves;Anthony Wing-Hung Chan
- 期刊名称：《Liver Cancer》 | 2020年第2期
- Inflammation;
- Liver cancer;
- Prognosis;
- Tumor markers;
94.Gene Signature for Sorafenib Susceptibility in Hepatocellular Carcinoma: Different Approach with a Predictive Biomarker

机译：肝细胞癌中索拉非尼易感性的基因签名：具有预测性生物标志物的不同方法。
- 作者：Chang Min Kim;Shin Hwang;Bhumsuk Keam;Yun Suk Yu;Ji Hoon Kim;Dong-Sik Kim;Si Hyun Bae;Gun-Do Kim;Jong Kyu Lee;Yong Bae Seo;Soon Woo Nam;Koo Jeong Kang;Luigi Buonaguro;Jin Young Park;Yun Soo Kim;Hee Jung Wang
- 期刊名称：《Liver Cancer》 | 2020年第2期
- Sorafenib;
- Biomarker;
- Gene signature;
- Hepatocellular carcinoma;
95.Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with Lenvatinib

机译：Lenvatinib治疗的肝细胞癌患者的骨骼肌质量影响其耐受性和预后
- 作者：Haruki Uojima;Makoto Chuma;Yoshiaki Tanaka;Hisashi Hidaka;Takahide Nakazawa;Shogo Iwabuchi;Satoshi Kobayashi;Nobuhiro Hattori;Katsuaki Ogushi;Manabu Morimoto;Tatehiro Kagawa;Katsuaki Tanaka;Makoto Kako;Wasaburo Koizumi
- 期刊名称：《Liver Cancer》 | 2020年第2期
- Skeletal muscle mass;
- Hepatocellular carcinoma;
- Lenvatinib;
96.Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy

机译：基线Mac-2结合蛋白糖基化异构体水平确定了口服抗病毒治疗的慢性乙型肝炎患者肝细胞癌的风险
- 作者：Tai-Chung Tseng;Cheng-Yuan Peng;Yao-Chun Hsu;Tung-Hung Su;Chia-Chi Wang;Chun-Jen Liu;Hung-Chih Yang;Wan-Ting Yang;Chia-Hsin Lin;Ming-Lung Yu;Hsueh-Chou Lai;Yasuhito Tanaka;Mindie H. Nguyen;Chen-Hua Liu;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao
- 期刊名称：《Liver Cancer》 | 2020年第2期
97.Comprehensive Consideration before the Decision-Making of the Systemic Treatment in Patients with Advanced Hepatocellular Carcinoma

机译：晚期肝细胞癌患者进行全身治疗之前的综合考虑
- 作者：Mingyu Chen;Jiahao Hu;Jiasheng Cao;Xiujun Cai
- 期刊名称：《Liver Cancer》 | 2020年第2期
98.Response to the Comments on Rimassa et al.: Systemic Treatment Options in Hepatocellular Carcinoma

机译：对关于Rimassa等人的评论的回应：肝细胞癌的全身治疗选择
- 作者：Lorenza Rimassa;Tiziana Pressiani;Philippe Merle
- 期刊名称：《Liver Cancer》 | 2020年第2期
99.Synthetic Lethality Is a Novel and Potential Paradigm for Precision Medicine in Advanced Hepatocellular Carcinoma

机译：合成致死性是晚期肝细胞癌精准医学的一种新的和潜在的范例。
- 作者：Mingyu Chen;Xiujun Cai
- 期刊名称：《Liver Cancer》 | 2020年第2期
100.Combination Cancer Immunotherapy with Molecular Targeted Agents/Anti-CTLA-4 Antibody for Hepatocellular Carcinoma

机译：分子靶向药物/抗CTLA-4抗体联合抗癌免疫疗法治疗肝细胞癌
- 作者：Masatoshi Kudo
- 期刊名称：《Liver Cancer》 | 2019年第1期